JSPR
Jasper Therapeutics, Inc. · Healthcare
Insiders bought $347K net in the last 90 days ·0 sellers, 4 buyers· latest Form 4 filed Sep 24, 2025
Insider Buying
$347K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 24, 2025
WIGGANS THOMAS G
Jasper Therapeutics, Inc. (JSPR) has 4 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 24, 2025.
Inside the rolling window, 4 insiders at Jasper Therapeutics, Inc. reported 4 open-market purchases totaling $347K and no open-market sales. Insiders have net bought $347K over the trailing 6 months. The most recent open-market filing is a purchase of 41,000 shares by Director WIGGANS THOMAS G, dated Sep 22, 2025, worth $100K.
- Industry:Biotechnology
- CEO:Jeetinder Singh Mahal
- Employees:22
- HQ:Redwood City, CA, US
- IPO:2020-01-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
WIGGANS THOMAS GFirst filing | Director | Purchase | 41,000 | $100K | Sep 24 | — | SEC ↗ |
Lucas SvetlanaFirst filing | Director | Purchase | 20,000 | $49K | Sep 24 | — | SEC ↗ |
MARTELL RONFirst filing | President and CEO | Purchase | 41,000 | $100K | Sep 24 | — | SEC ↗ |
Shizuru Judith AnneFirst filing | Director | Purchase | 41,000 | $100K | Sep 24 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does JSPR have?
Jasper Therapeutics, Inc. (JSPR) has 4 SEC Form 4 filings (4 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 24, 2025.
When was the most recent SEC Form 4 filing for JSPR?
The most recent Form 4 filing for JSPR on Tracefour is dated Sep 24, 2025.
What is the net insider flow at JSPR over the last 6 months?
Over the trailing 180 days, insiders at JSPR have net bought $347K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at JSPR in the current window?
Inside the rolling window, insiders at JSPR bought $347K and sold $0 based on SEC Form 4 filings.
Can I get alerts for JSPR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Jasper Therapeutics, Inc. (JSPR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Jasper Therapeutics, Inc. is in the Healthcare sector.